Markets
NVAX Watch
Novavax
$7.9
$-0.28 -3.42%
1 Min 5 Min 15 Min Hourly Daily
Assets Gross Profit Revenue Earnings
Chart Sentiment News Fundamentals About
Jake__Wujastyk
@jake__wu...
48.5% Winrate 2.5% Avg Gain 43.9% S&P Beat
Bought NVAX Shares
16d agoSwungBullish
down -4.84% At 8.27, Exited 7.87
This is the BS media shit thats probably going to move this and other names like $MRNA $PFE etc.
Exited 8d ago
0 0
Stonks
@stocks
46.4% Winrate 5.4% Avg Gain 15.8% S&P Beat
Bought NVAX Shares
39d agoSwungBullish
down -10.36% At 9.07, Exited 8.13
I believe Novavax is currently undervalued at around $9 and has strong potential to double or even triple its stock price this year. The recent buyout... Read More
Exited 32d ago
0 0
MoonTrades7
@moontrad...
13.2% Winrate -14.3% Avg Gain -1896.5% S&P Beat
Bought NVAX Calls
43d agoDaytradedBullish
down -11.59% At 0.28, Exited 0.24
Contract: 10 Strike Call for Jan 31
THIS CAN GO 1,000%
Exited 41d ago
0 0
Scalp
@scalpgan...
44.4% Winrate 108.5% Avg Gain 4606.9% S&P Beat
Bought NVAX Shares
88d agoSwungBullish
down -3.76% At 9.04, Exited 8.7
I've got a strong position in NVAX right now because of three major catalysts that the market hasn't fully absorbed yet. With recent milestones reache... Read More
Exited 81d ago
0 0
Long
@long_gam...
44.3% Winrate 16.2% Avg Gain 135.0% S&P Beat
Shorted NVAX Shares
116d agoSwungBearish
down -19.13% At 7.11, Exited 8.47
Given the disconnect between the positive developments in the malaria vaccine and NVAX's poor stock performance, I believe it’s wise to short NVAX. Th... Read More
Exited 109d ago
0 0
Degenerate
@wsb
43.4% Winrate 13.8% Avg Gain 453.1% S&P Beat
Bought NVAX Shares
156d agoSwungBullish
down -7.27% At 13.61, Exited 12.62
I'm really optimistic about NVAX, especially after their deal with Sanofi which should drive revenue and growth. With a 30% short interest, I'm antici... Read More
Exited 148d ago
0 0
Biostonks69
@9n6g89hh...
60.0% Winrate 1.6% Avg Gain 2.8% S&P Beat
Bought NVAX Shares
207d agoInvestedBullish
down -39.01% At 12.98, Now 7.92
Riding the wave of the smallpox fear. Company has good financials with $1B cash on hand and in a good position to receive government funding, grants, ... Read More
Degenerate
@wsb
43.4% Winrate 13.8% Avg Gain 453.1% S&P Beat
Bought NVAX Shares
207d agoInvestedBullish
down -44.12% At 12.92, Exited 7.22
Novavax is well-positioned to capitalize on the monkeypox outbreak with its proven vaccine platform, strong financial position, and potential for gove... Read More
Exited 117d ago
1 1
Two
@two-sigm...
58.1% Winrate 10.8% Avg Gain -21.0% S&P Beat
Bought NVAX Shares
255d agoInvestedBullish
down -37.62% At 12.73, Now 7.92
Trims & Adds [ ] Currently down $9.6M
[+] 163d ago
Added 656.9K shares @ 12.63
[+] 255d ago
Initial 1.3M shares @ 12.73
Renaissance
@renaissa...
57.4% Winrate 4.3% Avg Gain -11.6% S&P Beat
Bought NVAX Shares
255d agoInvestedBullish
down -37.56% At 12.73, Now 7.92
Trims & Adds [ ] Currently down $9.8M
[+] 163d ago
Added 954.6K shares @ 12.63
[+] 255d ago
Initial 1.1M shares @ 12.73
Point72
@point72-...
52.2% Winrate 5.1% Avg Gain -17.7% S&P Beat
Bought NVAX Shares
2.0y agoInvestedBullish
up 44.69% At 6.93, Now 7.92
Trims & Adds [ ] Currently up $1.6M
[-] 163d ago
Trimmed 34.8K shares @ 12.63
[-] 255d ago
Trimmed 151.5K shares @ 12.73
[+] 346d ago
Added 100.0K shares @ 4.65
[+] 1.2y ago
Added 79.8K shares @ 5.03
[-] 1.4y ago
Trimmed 255.0K shares @ 7.09
[+] 1.7y ago
Added 70.0K shares @ 7.43
[+] 2.0y ago
Initial 310.0K shares @ 6.93
Two
@two-sigm...
58.1% Winrate 10.8% Avg Gain -21.0% S&P Beat
Bought NVAX Shares
2.2y agoInvestedBullish
down -19.1% At 9.79, Now 7.92
Sign in or create an account Get notifications, save trades, and more
google logo Continue with Google Continue with Email
By continuing, you agree to our Terms and Privacy Policy.